首页> 美国卫生研究院文献>Acta Crystallographica. Section D Structural Biology >The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab
【2h】

The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab

机译:埃博拉病毒的Bundibugyo株与泛特异性合成Fab的复合物中核蛋白C末端结构域的结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The vast majority of platforms for the detection of viral or bacterial antigens rely on immunoassays, typically ELISA or sandwich ELISA, that are contingent on the availability of suitable monoclonal antibodies (mAbs). This is a major bottleneck, since the generation and production of mAbs is time-consuming and expensive. Synthetic antibody fragments (sFabs) generated by phage-display selection offer an alternative with many advantages over Fabs obtained from natural antibodies using hybridoma technology. Unlike mAbs, sFabs are generated using phage display, allowing selection for binding to specific strains or for pan-specificity, for identification of structural epitopes or unique protein conformations and even for complexes. Further, they can easily be produced in Escherichia coli in large quantities and engineered for purposes of detection technologies and other applications. Here, the use of phage-display selection to generate a pan-specific Fab (MJ20), based on a Herceptin Fab scaffold, with the ability to bind selectively and with high affinity to the C-terminal domains of the nucleoproteins (NPs) from all five known strains of the Ebola virus is reported. The high-resolution crystal structure of the complex of MJ20 with the antigen from the Bundibugyo strain of the Ebola virus reveals the basis for pan-specificity and illustrates how the phage-display technology can be used to manufacture suitable Fabs for use in diagnostic or therapeutic applications.
机译:用于检测病毒或细菌抗原的绝大多数平台都依赖于免疫测定,通常是ELISA或夹心ELISA,这取决于合适的单克隆抗体(mAb)的可用性。这是一个主要的瓶颈,因为mAb的产生和生产既费时又昂贵。通过噬菌体展示选择产生的合成抗体片段(sFabs)提供了一种替代方法,与使用杂交瘤技术从天然抗体获得的Fabs相比具有许多优势。与mAb不同,sFabs是通过噬菌体展示产生的,可以选择结合特定菌株或泛特异性,鉴定结构表位或独特的蛋白质构象,甚至复合物。此外,它们可以轻松地在大肠杆菌中大量生产,并经过工程设计以用于检测技术和其他应用。在这里,基于赫赛汀Fab支架,使用噬菌体展示选择来产生泛特异性Fab(MJ20),该抗体具有选择性结合并与核糖核酸(NP)的C末端结构域具有高亲和力的能力报道了埃博拉病毒的所有五种已知菌株。 MJ20与埃博拉病毒Bundibugyo菌株抗原的复合物的高分辨率晶体结构揭示了泛特异性的基础,并说明了噬菌体展示技术如何可用于制造用于诊断或治疗的合适Fab应用程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号